323 related articles for article (PubMed ID: 32460180)
1. Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.
Mathew AS; Atenafu EG; Owen D; Maurino C; Brade A; Brierley J; Dinniwell R; Kim J; Cho C; Ringash J; Wong R; Cuneo K; Feng M; Lawrence TS; Dawson LA
Eur J Cancer; 2020 Jul; 134():41-51. PubMed ID: 32460180
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities.
Que JY; Lin LC; Lin KL; Lin CH; Lin YW; Yang CC
Radiat Oncol; 2014 May; 9():120. PubMed ID: 24885086
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
Liu HY; Lee Y; McLean K; Leggett D; Hodgkinson P; Fawcett J; Mott R; Stuart K; Pryor D
Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e194-e202. PubMed ID: 32345457
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
[TBL] [Abstract][Full Text] [Related]
5. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
[TBL] [Abstract][Full Text] [Related]
6. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
[TBL] [Abstract][Full Text] [Related]
7. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M
J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
[TBL] [Abstract][Full Text] [Related]
9. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion.
Munoz-Schuffenegger P; Barry A; Atenafu EG; Kim J; Brierley J; Ringash J; Brade A; Dinniwell R; Wong RKS; Cho C; Kim TK; Sapisochin G; Dawson LA
Radiother Oncol; 2021 Mar; 156():120-126. PubMed ID: 33285195
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity.
Bibault JE; Dewas S; Vautravers-Dewas C; Hollebecque A; Jarraya H; Lacornerie T; Lartigau E; Mirabel X
PLoS One; 2013; 8(10):e77472. PubMed ID: 24147002
[TBL] [Abstract][Full Text] [Related]
12. Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies.
Kibe Y; Takeda A; Tsurugai Y; Eriguchi T
Acta Oncol; 2020 Aug; 59(8):888-894. PubMed ID: 32216593
[No Abstract] [Full Text] [Related]
13. Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.
Que J; Kuo HT; Lin LC; Lin KL; Lin CH; Lin YW; Yang CC
BMC Cancer; 2016 Jul; 16():451. PubMed ID: 27405814
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma.
Yamashita H; Onishi H; Murakami N; Matsumoto Y; Matsuo Y; Nomiya T; Nakagawa K;
J Radiat Res; 2015 May; 56(3):561-7. PubMed ID: 25691453
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma.
Yoon SM; Lim YS; Park MJ; Kim SY; Cho B; Shim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Lee YS; Park JH; Kim JH
PLoS One; 2013; 8(11):e79854. PubMed ID: 24255719
[TBL] [Abstract][Full Text] [Related]
16. SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.
Qiu H; Moravan MJ; Milano MT; Usuki KY; Katz AW
J Gastrointest Cancer; 2018 Dec; 49(4):463-469. PubMed ID: 28710606
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma.
Shen PC; Chang WC; Lo CH; Yang JF; Lee MS; Dai YH; Lin CS; Fan CY; Huang WY
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):307-318. PubMed ID: 31175903
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.
Gerum S; Heinz C; Belka C; Walter F; Paprottka P; De Toni EN; Roeder F
Radiat Oncol; 2018 May; 13(1):100. PubMed ID: 29843752
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas - A Single Institution Phase II Study.
Beaton L; Dunne EM; Yeung R; Rackley T; Weber B; Mar C; Yong-Hing CJ; Yoshida EM; DeVries K; Lee R; Duzenli C; Loewen SK; Liu M; Schellenberg D; Ma R
Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):423-432. PubMed ID: 32093876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
